UNSPSC 51151522: Hexafluorenium or hexafluronium

This classification denotes an acetylcholinesterase inhibitor with the molecular formula C36H42N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 55W5L6G81R, chemically known as 1,6-hexanediaminium, n, n-di-9h-fluoren-9-yl-n,n,n,n-tetramethyl-, dibromide but generally known as hexafluorenium, which bears US NIH Compound Identifier 3601. Hexafluorenium or hexafluronium bears US NLM identifiers UMLS ID C0062619 and NCI Concept Code C76138. SMILES: C[N+](C)(CCCCCC[N+](C)(C)C1C2=CC=CC=C2C3=CC=CC=C13)C4C5=CC=CC=C5C6=CC=CC=C46.

UNSPSC 51151522 Hexafluorenium or hexafluronium is a Commodity code with minimal recent state and local procurement activity directly aligned to its nominal pharmaceutical scope. The recent opportunities tagged to this code show a mismatch with the substance itself: Seminole County, Florida solicited naloxone and drug deactivation systems through an IFB (IFB60459723LAS, response due July 26, 2023), and the Texas Health and Human Services Commission issued an RFI on therapeutic pharmacy initiatives focused on direct-to-manufacturer prescription fulfillment. Neither procurement targets hexafluorenium specifically, and both address broader pharmaceutical procurement frameworks rather than a single chemical agent. The Seminole County opportunity involves annual purchases of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries, whereas the Texas HHS RFI seeks vendor capabilities for implementing direct contracting between state pharmacy benefit programs and manufacturers outside traditional PBM and GPO channels.

The geographic activity reflects scattered state and local engagement across Florida and Texas, with no clear concentration or pattern of repeat buyers under this code. Issuing bodies include county health departments (Seminole County) and state health agencies (Texas HHS), but the sample is too sparse to characterize a robust marketplace. No explicit set-asides, dollar values, or future procurement intent are documented in the recent record. The Seminole County IFB required electronic bidding through the county portal with drug-free workplace and E-Verify compliance; the Texas RFI specified no formal evaluation criteria or bidders' meetings, functioning instead as an exploratory market-intelligence phase ahead of formal solicitation. Given the mismatch between the code's pharmaceutical substance designation and the actual scope of recent tagged opportunities, this code shows little relevant procurement activity for hexafluorenium itself.